SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]:
SEC Accession No. 0001052918-20-000175
Filing Date
2020-07-21
Accepted
2020-07-21 07:12:17
Documents
10
Period of Report
2019-07-31

Document Format Files

Seq Description Document Type Size
1 AVRICORE HEALTH INC. FORM 6-K avricore6kjuly2019.htm 6-K 9092
2 STATEMENT OF EXECUTIVE COMPENSATION ex99-1.htm EX-99 69348
3 NEWS RELEASE ex99-2.htm EX-99 8342
4 NEWS RELEASE ex99-3.htm EX-99 9647
5 NEWS RELEASE ex99-4.htm EX-99 4007
6 CODE OF CONDUCT ex99-5.htm EX-99 37633
7 ex9911.jpg GRAPHIC 43293
8 ex9951.jpg GRAPHIC 54915
9 ex9952.jpg GRAPHIC 6636
10 avricore6kjuly20191.jpg GRAPHIC 2400
  Complete submission text file 0001052918-20-000175.txt   287471
Mailing Address 789 WEST PENDER STREET SUITE 810 VANCOUVER A1 V6C 1H2
Business Address 789 WEST PENDER STREET SUITE 810 VANCOUVER A1 V6C 1H2 604-687-2038
Avricore Health Inc. (Filer) CIK: 0001355736 (see all company filings)

IRS No.: 000000000 | State of Incorp.: A1 | Fiscal Year End: 1231
Type: 6-K | Act: 34 | File No.: 000-51848 | Film No.: 201037670
SIC: 2834 Pharmaceutical Preparations